A. Bruce Moore Jr - Feb 16, 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 16, 2022
Transactions value $
-$7,406,188
Form type
4
Date filed
2/18/2022, 05:47 PM
Previous filing
Feb 1, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale -$5.03M -20.6K -16.94% $244.01 101K Feb 16, 2022 Direct F1
transaction HCA Common Stock Sale -$2.37M -9.37K -9.26% $253.18 91.8K Feb 17, 2022 Direct F2
holding HCA Common Stock 40.6K Feb 16, 2022 By MAM Trust (Spouse, Trustee)
holding HCA Common Stock 44.5K Feb 16, 2022 By MRM Trust (Spouse, Trustee)
holding HCA Common Stock 40.6K Feb 16, 2022 By TCM Trust (Spouse, Trustee)
holding HCA Common Stock 51.1K Feb 16, 2022 By 2018 GRAT
holding HCA Common Stock 100K Feb 16, 2022 By 2021 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.00 to $244.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.10 to $253.45, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.